Publication | Open Access
Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP
26
Citations
5
References
2021
Year
This study provides Class II evidence that CSF IL-8 levels accurately distinguish patients with GBS from those with CIDP.
| Year | Citations | |
|---|---|---|
Page 1
Page 1